Final results for the year ended 31 March 2021

15th July 2021

Nuformix plc (LSE:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing to provide enhanced benefit, announces its audited results for the year ended 31 March 2021.

Download News

Back to all News